Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06533228 · ClinicalTrials.gov registry record
Helmsley 3.0: Abbreviated MRE
A clinical trial of Crohn's Disease, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- 300
- Enrollment target
- 2
- Study locations
NCT06533228 is a study of Crohn's Disease that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 300 participants, below the 2,412-participant average among 104 other Crohn's Disease trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06533228, a study of Crohn's Disease, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of our study is to compare an abbreviated magnetic resonance imaging (MRI) of the bowel or magnetic resonance enterography (MRE) protocol to a conventional, standard of care MRE in children and adults with Crohn's Disease.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Magnetic Resonance Imaging (MRI) or Magnetic Resonance Enterography (MRE)
Study Locations (2)
Minnesota
- Mayo Clinic - Rochester
New York
- NYU Langone - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-09-01 |
| Est. Completion | 2028-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06533228
The ClinicalTrials.gov registry entry for NCT06533228 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,412-participant average among 104 other Crohn's Disease trials with a reported enrollment target (88% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Crohn's Disease appearing as the primary indexed condition, and to 1 intervention - of which Magnetic Resonance Imaging (MRI) or Magnetic Resonance Enterography (MRE) is the first listed.
NCT06533228 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Minnesota, New York.
Frequently Asked Questions
What is clinical trial NCT06533228 about?
NCT06533228 is a clinical study titled "Helmsley 3.0: Abbreviated MRE". The purpose of our study is to compare an abbreviated magnetic resonance imaging (MRI) of the bowel or magnetic resonance enterography (MRE) protocol to a conventional, standard of care MRE in children and adults with Crohn's Disease.
What is the current status of trial NCT06533228?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2024-09-01. Estimated completion is 2028-02.
What conditions does trial NCT06533228 study?
This clinical trial studies the following conditions: Crohn's Disease.
What interventions are being tested in trial NCT06533228?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) or Magnetic Resonance Enterography (MRE) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06533228?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06533228 being conducted?
This trial has 2 study locations across Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Crohn's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease
RECRUITING · NA
-
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
RECRUITING · Phase 2
-
Behavioral Therapy for Crohn's Disease
RECRUITING · NA
-
Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
RECRUITING · Phase 3
-
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
RECRUITING · Phase 4
-
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.